-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – BMS-986218 in Colorectal Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - BMS-986218 in Colorectal Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. BMS-986218 in Colorectal Cancer Drug Details: BMS-986218 is under development for...
-
Thematic Analysis
Quantum Computing in Aerospace, Defense and Security – Thematic Intelligence
Quantum Computing in Aerospace and Defense Thematic Report Overview Quantum computing aims to use the counterintuitive behavior of sub-atomic particles to spawn computers of mind-boggling power. Quantum computers can simulate large, uncertain, complicated systems in seconds, including the weather, financial markets, chemical reactions, molecules, and neurons in the human brain. In the aerospace and defense industry quantum capabilities are theorized to have applications in sensing, communications, computing, navigation, and electronic warfare, with the unique properties of quantum mechanics enhancing situational...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – TRGFT-201 in Hematopoietic Stem Cell Transplantation
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - TRGFT-201 in Hematopoietic Stem Cell Transplantation report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. TRGFT-201 in Hematopoietic Stem Cell Transplantation Drug Details: TRGFT-201 is...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Orca-Q in Myelofibrosis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Orca-Q in Myelofibrosis report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Orca-Q in Myelofibrosis Drug Details: Orca-Q is under development for the treatment...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Orca-Q in Myelodysplastic Syndrome
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Orca-Q in Myelodysplastic Syndrome Drug Details: Orca-Q is under development for the treatment of acute...
-
Thematic Analysis
Quantum Computing – Thematic Intelligence
Quantum Computing Theme Analysis Report Overview Quantum computers use the properties of quantum physics to store data and perform computations. There are many technologies with the potential to build their foundational quantum bits (qubits). However, it may well be over a decade before companies can deliver the enmeshed systems of high-fidelity qubits needed to usher in the quantum era. The fiendishly difficult engineering problems, excess hype, and pre-revenue phase for many quantum companies mean a protracted quantum winter is in...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Allogeneic Donor-Derived T-Cells Transduced With Bivalent Lentiviral Vector (CD19/CD22-BBz) Chimeric Antigen Receptor (CAR) in B-Cell Acute Lymphocytic Leukemia (B-Cell Acute Lymphoblastic Leukaemia)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Allogeneic Donor-Derived T-Cells Transduced With Bivalent Lentiviral Vector (CD19/CD22-BBz) Chimeric Antigen Receptor (CAR) in B-Cell Acute Lymphocytic Leukemia (B-Cell Acute Lymphoblastic Leukaemia) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using...
-
Product Insights
NewHematopoietic Stem Cell Transplantation – Drugs In Development, 2024
Empower your strategies with our Hematopoietic Stem Cell Transplantation – Drugs In Development, 2024 report and make more profitable business decisions. Hematopoietic stem-cell transplantation (HSCT) is the transplantation of multipotent hematopoietic stem cells, usually derived from bone marrow, peripheral blood, or umbilical cord blood in order to replicate inside of a patient and to produce additional normal blood cells. It may be autologous (the patient's own stem cells are used), allogeneic (the stem cells come from a donor) or syngeneic (from...